Schwannoma

Schwannoma is a benign, encapsulated neoplasm derived from the myelinating Schwann cells of the peripheral nervous system.[1] Classified under peripheral nerve sheath tumors in the WHO Classification of Tumours (5th edition, 2020), it is the most common [2]benign peripheral nerve sheath tumor.[3][4] In the oral and maxillofacial region, schwannomas arise most frequently in the soft tissues—particularly the tongue—but rarely occur as intraosseous lesions within the jaws, where they account for less than 1% of primary benign bone tumors.[1][5] The tumor grows eccentrically along a single nerve fascicle, displacing rather than infiltrating the parent nerve, and is typically well encapsulated.[6] On dental radiographs, intraosseous schwannomas characteristically present as well-defined unilocular radiolucencies with a corticated border. Treatment is surgical excision, which is curative in the vast majority of cases.[1][7]

• Schwannoma is the current preferred term in the WHO Classification of Tumours (5th edition, 2020), listed under peripheral nerve sheath tumors.[2]
• Neurilemmoma (also spelled neurilemoma) is a widely recognized synonym that remains in clinical use.[1][8]
• Neurinoma is an older term, now largely obsolete in English-language literature but still encountered in some European publications.
• The tumor should not be confused with neurofibroma, which is a distinct entity arising from multiple cell types within the nerve sheath and growing centrally within the nerve rather than eccentrically.[4][6]

• Age: Broad age range (8–77 years in jaw series); mean age approximately 37 years.[1]
• Sex: Slight female predominance reported in most series.[1][9]
• Frequency: Schwannomas are the most common benign peripheral nerve sheath tumor overall. In the oral cavity, they are uncommon; intraosseous jaw schwannomas are rare, with approximately 160 cases of intraosseous benign peripheral nerve sheath tumors reported in the jaws to date.[3][5]
• Soft-tissue distribution: Tongue is the most common intraoral site, followed by palate, buccal mucosa, gingiva, and lips.[1][10]
• Intraosseous distribution: The posterior mandible is the most common jaw location, accounting for the majority of intraosseous cases. The maxilla is affected far less frequently. Among intraosseous mandibular schwannomas, the inferior alveolar nerve is the most commonly involved nerve.[1][7][11]

Presentation and Symptoms

• Painless swelling is the most common presentation of mandibular schwannomas; over half of patients present with swelling without pain.[1]
• Pain without swelling occurs in a minority of cases.[1]
• Numbness and paresthesia of the lower lip or chin (inferior alveolar nerve distribution) are characteristic when the tumor arises from or compresses the inferior alveolar nerve. These sensory deficits may prompt earlier clinical detection compared with schwannomas of less symptomatic nerves.[1]
• A small proportion of patients are entirely asymptomatic, with the lesion discovered incidentally on routine radiographs.[1]

Examination Findings

• Buccal or lingual cortical expansion may be palpable, typically firm and non-tender.[1][11]
• Overlying mucosa is usually intact and normal in color.
• Tooth vitality may be compromised in the region of the tumor.[1]

Tempo and Complications

• Growth is characteristically slow, often present for months to years before diagnosis.[6][12]
• Tumor sizes range from 0.5 cm to 12 cm.[1]
• Pathologic fracture is a rare complication of large lesions with extensive cortical thinning.[13]
• Malignant transformation is exceedingly rare (less than 1%).[12]

Location and Distribution

• Intraosseous schwannomas of the jaws show a strong predilection for the posterior mandible. The body and ramus are most frequently affected.[1][7]
• Maxillary involvement is uncommon.
• Tumors arising from the inferior alveolar nerve are centered along the course of the mandibular canal.[1][14]

Periphery and Shape

• The characteristic appearance is a well-defined, unilocular radiolucency with a thin sclerotic (corticated) border.[1][8][14]
• Shape is typically round to ovoid.
• Occasional cases present with an ill-defined or poorly corticated border, which can mimic aggressive or malignant lesions.[5][8]
• Multilocular appearances are uncommon but reported, further complicating the differential diagnosis.[5]

Internal Architecture

• The internal structure is most commonly radiolucent without internal calcification or septation.[1][14]
• On cross-sectional imaging, the lesion appears as a solid, homogeneous mass; cystic change is occasionally present and correlates with Antoni B–predominant histology or degenerative changes.[14][15]

Effects on Teeth and Adjacent Structures

• Tooth displacement is common when the tumor is in a tooth-bearing region.[1][11]
• Root resorption occurs as a result of mechanical pressure from the expanding mass.[1]
• Tooth vitality may be altered depending on proximity to the tumor.[1]
• Cortical thinning and expansion are observed in a substantial proportion of cases. Expansion is typically smooth and gradual, reflecting the slow growth rate.[1][11]
• Cortical perforation can occur in larger lesions but is not the rule; periosteal reaction is characteristically absent.[14]

Relationship to the Mandibular Canal

• A diagnostically useful feature is the tumor's intimate relationship with the inferior alveolar nerve canal. The canal may be encased by the mass.[14]
• Widening (fusiform expansion) of the inferior alveolar canal is an occasional but suggestive finding, observed in a minority of reported cases.[11]
• Destructive changes of the cortical wall of the mandibular canal may be identified on cross-sectional imaging, even when the overall canal course is preserved.[14]
• A fusiform lesion continuous with the nerve within the canal is occasionally demonstrated and, when present, is a helpful clue to neurogenic origin.[16]

Growth Pattern and Extent

• Growth is expansile and centrifugal, with the tumor displacing rather than infiltrating surrounding bone.[1][6]
• No periosteal reaction is expected.[14]
• Large tumors may extend beyond the mandible into the parapharyngeal or submandibular soft tissues.[17][18]

Variants and Mimics

• Rare cases present as a periapical radiolucency mimicking endodontic pathology.[8]
• Some lesions closely mimic the radiographic appearance of an odontogenic keratocyst or ameloblastoma, particularly when located in the posterior mandible with a well-corticated unilocular pattern.[8][13]

MRI

• On MRI, schwannomas are typically isointense to hypointense relative to muscle on T1-weighted images and hyperintense on T2-weighted images.[1][15][19]
• Contrast enhancement is variable; solid components enhance, while cystic or myxoid areas do not.[1][19]
• A target sign (peripheral hyperintense rim with central low signal on T2-weighted images) may be observed in soft-tissue schwannomas and reflects the histologic distinction between peripheral myxoid (Antoni B) and central fibrocollagenous (Antoni A) tissue. This sign is less reliably seen in intraosseous jaw lesions.[1][15][20]
• MRI is valuable for delineating the relationship of the tumor to the inferior alveolar nerve, demonstrating encasement of the mandibular canal, and assessing soft-tissue extension beyond bone.[14]
• MRI cannot reliably distinguish schwannoma from neurofibroma based on signal characteristics alone.[20][21]

Medical CT

• On contrast-enhanced CT, schwannomas may show low enhancement (reflecting Antoni B predominance) or heterogeneous enhancement with cystic areas.[15]
• CT is superior to panoramic radiography for evaluating cortical integrity, canal involvement, and cortical thinning or destruction.[14][22][23]

Intraosseous schwannoma of the jaws lacks pathognomonic radiographic features, and the differential diagnosis centers on other well-defined unilocular radiolucencies of the posterior mandible. The presence of inferior alveolar canal involvement, paresthesia, and absence of an odontogenic relationship may raise suspicion for a neurogenic tumor, but definitive diagnosis requires histopathologic examination.

The highest-risk diagnostic pitfall is misidentification of an intraosseous schwannoma as an odontogenic cyst or tumor, leading to inappropriate initial management. When a well-defined posterior mandibular radiolucency is accompanied by paresthesia or inferior alveolar canal widening, a neurogenic tumor should be considered and incisional biopsy with immunohistochemistry (S-100, SOX10) pursued before definitive surgery.[1][14]

Microscopic Features

• Schwannoma is an encapsulated tumor composed entirely of neoplastic Schwann cells.[6][26]
• The hallmark is the biphasic pattern of Antoni A and Antoni B areas:[6][26]
  • Antoni A areas are hypercellular, composed of compact spindle cells with elongated nuclei arranged in fascicles, whorls, or palisades. Verocay bodies—parallel rows of palisading nuclei flanking an acellular eosinophilic zone—are characteristic.[6][27]
  • Antoni B areas are hypocellular and myxoid, with loosely arranged spindle cells, microcysts, foamy histiocytes, and hyalinized blood vessels.[6][26]
• Perivascular hyalinization of thick-walled vessels is a consistent and diagnostically helpful feature.[6][26]
• Mitotic activity is typically low; degenerative nuclear atypia ("ancient change") may be present and should not be mistaken for malignancy.[6]

Immunohistochemistry

• S-100 protein: diffuse, strong positivity is the immunohistochemical hallmark, confirming Schwann cell origin.[1][6][27]
• SOX10: consistently positive.[27][28]
• EMA (epithelial membrane antigen): negative in tumor cells but positive in the perineurial capsule.[6][29]
• Neurofilament: typically negative within the tumor (axons are excluded from the mass), distinguishing schwannoma from neurofibroma.[6][27]
• CD34: positive focally in Antoni B areas, in contrast to the diffuse positivity seen in neurofibromas.[27]

Recognized Histologic Variants

• Cellular schwannoma: predominantly or exclusively Antoni A, lacking Verocay bodies; higher cellularity and mitotic rate but benign behavior.[6][30]
• Ancient schwannoma: degenerative changes including cyst formation, fibrosis, calcification, and nuclear pleomorphism without true malignant features.[6]
• Plexiform schwannoma: multinodular growth pattern; important to distinguish from plexiform neurofibroma (which is associated with NF1).[6][31]
• Epithelioid schwannoma: nests of epithelioid Schwann cells; SMARCB1/INI1 loss in approximately 42% of cases.[29][32]
• Melanotic schwannoma (malignant melanotic nerve sheath tumor per current WHO terminology): pigmented, unencapsulated, with metastatic potential; may be associated with Carney complex.[4][6]

Radiologic-Pathologic Correlation

The degree of Antoni A versus Antoni B predominance influences imaging characteristics. Antoni B–predominant tumors tend to show lower enhancement on CT and higher T2 signal on MRI, while Antoni A–predominant tumors are more solid and cellular.[6][15]

Surgical Treatment

• Complete surgical excision is the standard treatment and is curative for the vast majority of schwannomas.[1][7][10]
• For intraosseous mandibular schwannomas, enucleation through a mucoperiosteal flap with a bone window is the most commonly performed procedure.[7]
• Conservative (nerve-sparing) approaches are preferred when feasible, given the tumor's encapsulated nature and tendency to displace rather than infiltrate the parent nerve. Nerve preservation is achievable in the majority of inferior alveolar nerve schwannomas.[1]
• Sagittal split ramus osteotomy or segmental mandibulectomy may be required for large or posteriorly located lesions to improve access and facilitate reconstruction.[1][7]

Complications of Surgery

• Lower lip numbness or paresthesia may persist postoperatively, particularly when the inferior alveolar nerve must be sacrificed.[1]
• Pathologic fracture is a rare postoperative complication, especially after removal of large lesions with significant cortical loss.[13]

Recurrence and Prognosis

• The recurrence rate for mandibular intraosseous schwannomas is low, reported at approximately 6%, with all recurrences in one systematic review occurring in the posterior mandible.[1][7]
• Post-surgical outcomes are generally favorable; the large majority of patients show no recurrence on follow-up.[1][9]
• Malignant transformation of conventional schwannoma is exceedingly rare.[10][12]

Surveillance

• Clinical and radiographic follow-up is recommended after excision to monitor for recurrence, particularly for posterior mandibular lesions.[1][7]

Syndromic Associations

• Neurofibromatosis type 2 (NF2): Multiple schwannomas, including bilateral vestibular schwannomas, are the hallmark. Oral schwannomas occurring in the setting of NF2 should prompt evaluation for additional tumors.[4][26][33]
• Schwannomatosis (SWN): Characterized by multiple non-vestibular schwannomas without other NF2 features. Mosaic loss of SMARCB1/INI1 expression on immunohistochemistry is a reliable marker and may help identify syndromic cases from a single schwannoma.[4][33]
• Carney complex: Associated specifically with psammomatous melanotic schwannoma, an entity with distinct biologic behavior and metastatic potential.[4][6]

When a jaw schwannoma is diagnosed in a young patient or when multiple schwannomas are identified, genetic evaluation for NF2 or schwannomatosis should be considered.[4][33]